The DOI matches its Crossref record; 39 of the 41 references it cites were found in a registry or an index.
Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis
Open accessAbstract
Background: Anxiety, depression and fatigue are commonly reported by persons with multiple sclerosis (PwMS). Objectives: We estimated the prevalence of each factor in a representative sample of PwMS, and in subgroups defined by age, sex and disease duration, at cohort entry and over time. We further examined whether and how these factors clustered together. Methods: A population-based longitudinal cohort of 198 PwMS was followed 6-monthly for 2.5 years. The Hospital Anxiety and Depression Scale (HADS) was used to measure anxiety (cut-point >7) and depression (>7) and the Fatigue Severity Scale (FSS) to measure fatigue (≥5). Results: At cohort entry, prevalence of anxiety was 44.5% (95%CI 37–51%), depression 18.5% (95%CI 12.6–23.4%), and fatigue 53.7% (95%CI 47–61%). Fatigue was more common in males than females (RR 1.29, p =0.01), with attenuation of the effect after adjustment for Expanded Disability Status Scale (adjusted RR 1.18, p =0.13). Prevalence of anxiety (but not depression or fatigue) decreased by 8.1% per year of cohort observation (RR 0.92, 95%CI 0.86–0.98, p =0.009), with the effect more pronounced in women (14.6%, RR 0.85, 95%CI 0.79–0.93, –<0.001) than men (2.6%, RR 1.03, 95%CI 0.90–1.17, p =0.77). There was no apparent seasonal variation in the prevalence of any of the three factors ( p >0.05). All three factors occurred contemporaneously at cohort entry in a higher proportion of the cohort than expected by chance ( p <0.001). Conclusions: Anxiety, depression and fatigue are common in PwMS and tend to cluster together. The findings are important for clinical management of PwMS and to the exploration of possible shared causal biological pathways.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The lifetime prevalence of anxiety disorders ranges from 20% to 45% throughout the course of MS,1”
From EMDR treatment for anxiety in MS patients: A pilot study (2020) · cites this paper as [1]
In the citing paper
“Multiple sclerosis (MS) patients suffer from high levels of anxiety.”
From EMDR treatment for anxiety in MS patients: A pilot study (2020) · cites this paper as [1]
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
The validity of the Hospital Anxiety and Depression Scale
Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(01)00296-3 · Cited by 9,779
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Krupp, L. B. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520460115022 · Cited by 6,172
Multiple Sclerosis Severity Score: Using disability and disease duration to rate disease severity
Roxburgh, R. H. S. R., Seaman, S. R., Masterman, T., Hensiek, A. E., Sawcer, S. J., Vukusic, S., Achiti, I., Confavreux, C., Coustans, M., le Page, E., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000156155.19270.f8 · Cited by 963
Parsons, H. M. (1974) · Science · doi:10.1126/science.183.4128.922 · Cited by 615
Chwastiak, L., Ehde, D. M., Gibbons, L. E., Sullivan, M., Bowen, J. D., & Kraft, G. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1862 · Cited by 555
Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis
Simpson, S., Taylor, B. V., Blizzard, L., Ponsonby, A., Pittas, F., Tremlett, H. L., Dwyer, T., Gies, P. H., & van der Mei, I. A. F. (2010) · Annals of Neurology · doi:10.1002/ana.22043 · Cited by 481
Self-citationFatigue in multiple sclerosis and its relationship to depression and neurologic disability
Bakshi, R., Shaikh, Z. A., Miletich, R. S., Czarnecki, D., Dmochowski, J., Henschel, K., Janardhan, V, Dubey, N., & Kinkel, P. R. (2000) · Multiple Sclerosis Journal · doi:10.1177/135245850000600308 · Cited by 480
Cited by
Sorted by citations
Items 201–295 of 295
Behavioral disorders in multiple sclerosis: a comprehensive review
Jellinger, K. A. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02816-9 · Cited by 6
Aging and the neuropsychiatry of multiple sclerosis: a cross-sectional study
Freedman, D., Oh, J., Einstein, G., & Feinstein, A. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13116-x · Cited by 9
“Although most studies fail to find a link between chronological age and depression [8, 13, 14, 16–19, 22– 25], a few report a An additional limitation of the existing literature is that most studies examine how age influences one [10, 15, 20, 22, 23, 26, 28–37], two [8, 13, 17–19, 21, 24, 25, 38,…”
InfluentialPsychische Störungen bei somatischen Krankheiten
Kapfhammer, H. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_88 · Cited by 6
Azoulai, M., Lévy-Heidmann, T., Morisseau, V., Wilczynski, O., Le, H. H., Jamieson, C., Charvet, L. E., Krupp, L., & Lair, L. L. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103637 · Cited by 5
Klein, I., Verhaak, C. M., Smeitink, J. A. M., de Laat, P., Janssen, M. C. H., & Custers, J. A. E. (2022) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12546 · Cited by 4
“Studies in other progressive diseases such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and incurable cancer showed fatigue levels remained largely stable,13–16 and depressive and anxiety symptoms were highly common.(17,18) The influence of disease-related and psychosocial variables on the course of…”
BackgroundLing, S., Moss, B. P., Wang, Z., & Sullivan, A. B. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104186 · Cited by 5
“For example, a cohort study (Wood et al., 2013) shows anxiety (44.”
Fatigue and depression influence the prevalence of anxiety in patients with multiple sclerosis
Nyári, A., Kokas, Z., Szamosi, S., Fricska‐Nagy, Z., Kincses, Z. T., Füvesi, J., Biernacki, T., Klivènyi, P., Bencsik, K., & Sandi, D. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07737-9 · Cited by 6
“[11, 12].”
Bianchi, V., & Pozzilli, C. (2015) · Neuropsychiatric symptoms of neurological disease · doi:10.1007/978-3-319-18464-7_10 · Cited by 6
Saul, A., Taylor, B. V., Blizzard, L., Simpson, S., Oddy, W. H., Shivappa, N., Hébert, J., Black, L. J., Ponsonby, A., Broadley, S., et al. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105468 · Cited by 5
Self-citationKapfhammer, H. (2014) · Neuropsychiatrie · doi:10.1007/s40211-014-0105-y · Cited by 4
Mulligan, H. F., Wilkinson, A., & Snowdon, J. (2017) · Physical Therapy Reviews · doi:10.1080/10833196.2017.1287393 · Cited by 6
Effects of Sensory Interventions on Fatigue in People With Multiple Sclerosis: A Systematic Review
Mohebbirad, M., Motaharinezhad, F., Shahsavary, M., & Joveini, G. (2021) · International Journal of MS Care · doi:10.7224/1537-2073.2020-123 · Cited by 4
“It consists of 27 items distributed across 5 subscales: (1) reporting (10 items); (2) external validity (3 items); (3) bias (7 items); (4) confounding (6 items); and (5) power (1 item).”
BackgroundIdentifying neuropsychological phenotypes in multiple sclerosis using latent profile analysis
Spiezia, A. L., Pontillo, G., Falco, F., Eliano, M., Lamagna, F., Esposito, A., Monaco, C. D., Nicolella, V., Novarella, F., Moccia, M., et al. (2025) · European Journal of Neurology · doi:10.1111/ene.70009 · Cited by 5
“Besides cognitive impairment, people with MS also have neurobehavioral issues, with fatigue being reported in up to 92%, de - pression in up to 42% and anxiety in up to 40% [ 4 ].”
Depressies bij multiple sclerose
Arts, N. J. M. (2013) · Tijdschrift voor Neuropsychiatrie en Gedragsneurologie · doi:10.1007/s40533-013-0003-9 · Cited by 4
Evaluation of neuropsychiatric symptoms in patients with multiple sclerosis
Öner, Ö. G., Totuk, Ö., Doğan, İ. G., CELİK, D., & Demir, S. (2022) · Çukurova medical journal (Online)/Çukurova medical journal · doi:10.17826/cumj.1018632 · Cited by 4
Mental health in adults living with arthrogryposis multiplex congenita
Sarveswaran, S., Mortenson, W. B., & Sawatzky, B. (2023) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.32042 · Cited by 4
“The mean HADS-D score was slightly higher than the mean (3.68 ± 3.07) of a sample of 1792 adults from the general U.K. population (Crawford et al., 2001), but less than a comparative population (5.5 ± 3.7) seen in a sample of 963 individuals in the United Kingdom with SCI (Woolrich et al., 2006).”
BackgroundResultInfluentialGroup Positive Psychotherapy and Depression of Females Affected by Multiple Sclerosis
Khayatan, T., Azkhosh, M., Bahmani, B., Azimian, M., & Dolatshahi, B. (2014) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 4
Seasonal variations in sleep disorders of nurses
Chang, Y., Lam, C., Chen, S., Sithole, T., & Chung, M. (2016) · Journal of Clinical Nursing · doi:10.1111/jocn.13519 · Cited by 4
“…in the prevalence of MDD was not observed in these patients © 2016 John Wiley & Sons Ltd 1086 Journal of Clinical Nursing, 26, 1085–1094 (Winthorst et al. 2011), in Australian patients with multiple sclerosis (Wood et al. 2013), and in patients with any anxiety disorder (Wood et al. 2013).”
BackgroundResultA clinical reasoning framework for fatigue for neurologic physical therapy
Cohen, E. T., Karpatkin, H., DiCarrado, S., & Zervas, M. (2020) · Physical Therapy Reviews · doi:10.1080/10833196.2020.1834329 · Cited by 6
Habitual and Low-Intensity Physical Activity in People with Multiple Sclerosis
Gullo, H., Hatton, A. L., Bennett, S. H., Fleming, J., & Shum, D. (2016) · Brain Impairment · doi:10.1017/brimp.2016.9 · Cited by 4
“%) in comparison to established prevalence rates in the MS population (Wood et al., 2013).”
ResultSources of Variability in Physical Activity Among Inactive People with Multiple Sclerosis
Uszynski, M., Herring, M. P., Casey, B., Hayes, S., Gallagher, S. M., Motl, R. W., & Coote, S. B. (2017) · International Journal of Behavioral Medicine · doi:10.1007/s12529-017-9674-z · Cited by 4
MULTİPL SKLEROZ HASTALARINDA ANKSİYETENİN MOTOR İMGELEME BECERİSİNE ETKİSİ
Kahraman, T., Savcı, S., Özdoğar, A. T., Gedik, Z., & İdıman, E. (2018) · Türk fizyoterapi ve rehabilitasyon dergisi · doi:10.21653/tjpr.416619 · Cited by 4
The Effect of Misophonia on the Severity of Depression and Anxiety in Multiple Sclerosis
Kenar, S. G., Yüksel, H., Şendur, N. K., & Mungan, S. (2022) · Turkish Journal Of Neurology · doi:10.4274/tnd.2022.93892 · Cited by 4
Vicente-Escudero, J. L. (2025) · Journal of Technology in Behavioral Science · doi:10.1007/s41347-025-00488-0 · Cited by 4
Šilić, P., Jeng, B., Jones, C. D., Huynh, T. L. T., Duffecy, J. L., & Motl, R. W. (2023) · Mental health and physical activity · doi:10.1016/j.mhpa.2023.100541 · Cited by 6
Esfahani, A. A., Pourshahbaz, A., & Dolatshahi, B. (2024) · BMC Public Health · doi:10.1186/s12889-024-18807-0 · Cited by 4
“It is a prevailing and debilitating symptom in patients with multiple sclerosis experienced as the most common symptom by over 80% of the affected ones [2, 5, 6] and reported by almost half of them as the most debilitating symptom even compared to physical pain and disability [7].”
BackgroundRetractedAnxiety and Multiple Sclerosis
Magistrale, G., & Nocentini, U. (2015) · Neuropsychiatric symptoms of neurological disease · doi:10.1007/978-3-319-18464-7_4 · Cited by 3
Aging With a Progressive Neurologic Disease
Karpatkin, H., & Cohen, E. T. (2019) · Topics in Geriatric Rehabilitation · doi:10.1097/tgr.0000000000000232 · Cited by 4
Data-driven analysis shows robust links between fatigue and depression in early multiple sclerosisPreprint
Chang, Y., Kearns, P. K. A., Carson, A. J., Gillespie, D. C., Meijboom, R., Kampaite, A., Hernández, M. D. C. V., Weaver, C., Stenson, A., MacDougall, N., et al. (2022) · medRxiv · doi:10.1101/2022.01.13.22269128 · Cited by 3
“Both are common complaints in pwMS and often coexist.(47) The association is bidirectional and challenging to disentangle, with identification of fatigue, or depression, increasing the risk of incident depression or fatigue, respectively.”
BackgroundLevine, S. L., Tabri, N., & Milyavskaya, M. (2021) · doi:10.31234/osf.io/zxg8h · Cited by 3
Morales, R. P., Ruíz, P. A. G., & Hernández, F. J. B. (2024) · Neurología · doi:10.1016/j.nrl.2023.06.011 · Cited by 2
Impact of fatigue on quality of life in adults with multiple sclerosis
Morales, R. P., Guirado-Ruiz, P. A., & Hernández, F. J. B. (2025) · Neurología (English Edition) · doi:10.1016/j.nrleng.2025.10.006 · Cited by 2
Yu, M., Coe, S., Tektonidis, T. G., Solsona, E. M., Middleton, R., Nicholas, R. S., Neate, S. L., Probst, Y., Davenport, R. A., Reece, J. C., et al. (2025) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2025.111756 · Cited by 2
Broche‐Pérez, Y., & Jiménez-Morales, R. M. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106919 · Cited by 3
Influence of religion and spirituality on the mental health of patients with multiple sclerosis
Khari, S., & Pazokian, M. (2023) · Journal of Spirituality in Mental Health · doi:10.1080/19349637.2023.2174920 · Cited by 2
“In a cohort study by Wood et al., 44.5% of MS patients had mild anxiety, and more than one-third experienced moderate to severe anxiety (Wood et al., 2013).”
BackgroundInfluentialEşkut, N., Köşkderelioğlu, A., Gedizlioğlu, M., & Önder, Ö. (2023) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_289_23 · Cited by 2
“[28] It is well known that sleep is an essential contributing factor to fatigue and tiredness in MS patients.”
BackgroundFalco, F., Lamagna, F., Espósito, A., Eliano, M., Spiezia, A. L., Petracca, M., Caliendo, D., Moccia, M., Lanzillo, R., Morra, V. B., et al. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105769 · Cited by 2
Silva‐Batista, C., Arpan, I., Nucci, M. P., & Horak, F. B. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.12.036 · Cited by 4
Rosa, L., Scandurra, C., Chiodi, A., Petracca, M., Costabile, T., Lauro, F. D., Moccia, M., Carotenuto, A., Maldonato, N. M., Morra, V. B., et al. (2022) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-022-09849-w · Cited by 3
“Thus, our results are not in line with previous studies finding associations between objective disability status and mental distress (Butler et al., 2016; Chwastiak & Ehde, 2007; Henry et al., 2019; Jones et al., 2014; Wood et al., 2013; Zorzon et al., 2001), while confirm previous research showing that people’s illne…”
ResultGlickman-Simon, R., & Mukherji, A. (2014) · EXPLORE · doi:10.1016/j.explore.2014.10.010 · Cited by 2
Propriedades psicométricas da Frontal Assessment Battery na esclerose múltipla
Henriques, S., Espírito‐Santo, H., Cunha, L., Lemos, L., & Daniel, F. (2019) · Revista Portuguesa de Investigação Comportamental e Social · doi:10.31211/rpics.2019.5.2.159 · Cited by 2
Ensari, I., & Elhadad, N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820077-3.00005-5 · Cited by 2
Psychische Störungen bei somatischen Krankheiten
Kapfhammer, H. (2015) · Springer eBooks · doi:10.1007/978-3-642-45028-0_88-1 · Cited by 2
Health, Wellness, and the Effect of Comorbidities on the Multiple Sclerosis Disease Course
Conway, D. S., Sullivan, A. B., & Rensel, M. R. (2023) · Neurologic Clinics · doi:10.1016/j.ncl.2023.06.007 · Cited by 2
Alexithymia in multiple sclerosis
Starynets, N. G., & Starynets, G. A. (2021) · Journal of Neurology & Stroke · doi:10.15406/jnsk.2021.11.00462 · Cited by 2
Safi, S. Z. (2015) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.5812/ijpbs.340 · Cited by 2
Strathdee, C. J., Krug, I., Malpas, C. B., & Kiropoulos, L. A. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107102 · Cited by 3
Needs, Challenges and Goals of Australian Women With Disabilities: A Preliminary Survey
Copas, S., & Dorstyn, D. (2014) · Australian Journal of Rehabilitation Counselling · doi:10.1017/jrc.2014.3 · Cited by 1
Symptomatic Treatment for Progressive Multiple Sclerosis
Rice, C. M., & Wilkins, A. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2395-8_8 · Cited by 1
Sadeqi, Y., Baghbanian, S. M., Bazi, A., Ghazaeian, M., & Fallah, S. (2023) · Current Journal of Neurology · doi:10.18502/cjn.v21i4.11717 · Cited by 2
Thoughts on Fatigue in Multiple Sclerosis Patients
Bakalidou, D., Giannopapas, V., & Giannopoulos, S. (2023) · Cureus · doi:10.7759/cureus.42146 · Cited by 2
“Furthermore, secondary factors, such as mental status, quality of life, direct sun exposure, and sleep quality, in addition to the patient’s tendency to organize their routines in ways that can minimize fatigue due to climatic conditions have been speculated but not properly investigated [24,25].”
BackgroundThe measurement of fatigability severity in individuals with multiple sclerosis and healthy controls
Alharbi, M. D., & Khan, F. R. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105568 · Cited by 1
Banasadegh, S., Shahrbanian, S., Gharakhanlou, R., Kordi, M. R., & Soltani, B. M. (2024) · Journal of Ethnicity in Substance Abuse · doi:10.1080/15332640.2024.2365230 · Cited by 1
“…factors have been identified as major contributors to MS risk, with factors such as Epstein–Barr virus (EBV) infection, smoking, sun exposure/vitamin D levels, and adolescent obesity and physical inactivity strongly associated with disease risk (Fernández‐Muñoz et al., 2015; Wood et al., 2013).”
ShahAli, S., Choobsaz, H., & Takamjani, I. E. (2021) · European Journal of Physiotherapy · doi:10.1080/21679169.2021.1958055 · Cited by 1
The contribution of cognitive behavioural factors to social anxiety in Parkinson’s disease
Nash, K., Dysch, L., Jones, J. T., MacQueen, R., & Marks, E. M. (2021) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465821000291 · Cited by 2
Ogden, J. (2014) · doi:10.1002/9781118715017.ch15 · Cited by 1
Vitamin D and Multiple Sclerosis : immunological and clinical outcome
Knippenberg, S. A. M. (2013) · Research Publications (Maastricht University) · doi:10.26481/dis.20130328sk · Cited by 1
Broche‐Pérez, Y., & Jiménez-Morales, R. M. (2024) · medRxiv · doi:10.1101/2024.06.23.24309357 · Cited by 1
Incidence of Anxiety in Patients with Multiple Sclerosis (MS)
Green, R. R., Kalina, J. T., & Pandey, K. S. (2015) · Journal of Intellectual Disability - Diagnosis and Treatment · doi:10.6000/2292-2598.2015.03.02.6
“populations, anxiety has been linked to social dysfunction and suicidal ideation [2, 10].”
BackgroundResultInfluentialÁhrif lyfsins Fampyra á göngugetu fólks með Multiple Sclerosis
Þórisson, J. M. (2015)
Determinants of Depression in Multiple Sclerosis
Berzins, S. A. (2014) · Libraries and Cultural Resources (University of Calgary) · doi:10.5072/prism/25602
Pharmacological and drug-free Interventions for Fatigue in Multiple Sclerosis
Penner, I. (2013) · Neurodegenerative Disease Management · doi:10.2217/nmt.12.80
Adapting mindfulness courses to the needs of people with MS
Bogosian, A. (2014) · Research Portal (King's College London)
Dehkordi, A. H., & Nikfarjam, M. (2016) · Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Kirmānshāh · doi:10.22110/jkums.v19i6.2567
Complex Symptoms and Mobility in Multiple Sclerosis Consensus Conference
Bennett, S. E., Béthoux, F., Tower, K., Finlayson, M. L., & Foley, F. W. (2014)
Лорина, Л. В., & Burshinov, A. O. (2017) · I P Pavlov Russian Medical Biological Herald · doi:10.23888/pavlovj20172316-327
Fatigue and associated factors in multiple sclerosis patients in Latvia
Setlere, S., Abelsen, A., Pastare, D., & Millers, A. (2018) · Neurologijos seminarai · doi:10.29014/ns.2018.05
Decision making under risk in multiple sclerosis
Radomski, A. D. (2013) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3bg2hh5w
Abu-AlHawa, M. (2018) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2018-13492
Safi, S. Z. (2020) · BiblioBoard Library Catalog (Open Research Library) · doi:10.5772/intechopen.86288
Fekih‐Romdhane, F., Ouali, U., Oumaya, M., Bouzid, R., Ridha, R., & Cheour, M. (2020) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2018.11.010
Symptomatic Treatment for Progressive Multiple Sclerosis
Bailey, S. M., & Rice, C. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-65921-3_7 · Cited by 2
hoseinzad, A., Khademi, A., Mashhadi, R. T., & Khalilzadeh, R. (2022) · Nursing and Midwifery Journal · doi:10.52547/unmf.20.7.529
Rudroff, T., & Workman, C. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89862-1.00026-x
The neuroimmunology of fatigue in multiple sclerosis
Ayache, S. S., & Chalah, M. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18578-6.00004-0
Salimi, L., Bahri, M. Z., & Pirkhaefi, A. (2024) · Health Nexus · doi:10.61838/kman.hn.2.1.14
پرست, ا. د., Rasouli, N., & Ghotb, S. I. (2024) · doi:10.61838/kman.jayps.5.6.16
Samami, E., Baghbanian, S. M., Nezhad, S. Z. H., Shahhosseini, Z., Moosazadeh, M., & Elyasi, F. (2025) · Neuropsychopharmacology Reports · doi:10.1002/npr2.70022
GUBSKAIA, K. V., Malygin, Y. V., Худяков, А. В., & Odnorob, E. N. (2025) · Neurology Bulletin · doi:10.17816/nb641670
Yu, M., Tektonidis, T. G., SOLSONA, E., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5374381
Clusters of Comorbidities in Multiple Sclerosis and Their Influence on Healthcare Resource Usage
Cárdenas‐Robledo, S., Otero‐Romero, S., García, J. D., López, N., Carbonell‐Mirabent, P., Rodríguez, M., Guío‐Sánchez, C., Carvajal, R., Passarell‐Bacradit, M. A., Sastre‐Garriga, J., et al. (2025) · European Journal of Neurology · doi:10.1111/ene.70386
“…is composed mainly of women, which is in line with the higher frequency of depression and anxiety in women in the general population [41], but disagrees with previous observations in MS, where no significant differences in the frequency of depression in both sexes have been reported [42–44].”
Ramirez, A. O., Keenan, A., Kalau, O., Worthington, E., Cohen, L., & Singh, S. (2021) · Figshare · doi:10.6084/m9.figshare.17120447
Ramirez, A. O., Keenan, A., Kalau, O., Worthington, E., Cohen, L., & Singh, S. (2021) · Figshare · doi:10.6084/m9.figshare.17120459
Ramirez, A. O., Keenan, A., Kalau, O., Worthington, E., Cohen, L., & Singh, S. (2021) · Figshare · doi:10.6084/m9.figshare.17120453
Ramirez, A. O., Keenan, A., Kalau, O., Worthington, E., Cohen, L., & Singh, S. (2021) · Figshare · doi:10.6084/m9.figshare.17120462
Brice, G., James, A. P., Rudaizky, D., et al. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107017
Exploring predictors of anxiety in patients with relapsing-remitting multiple sclerosis
Poprelka, K., Fasilis, T., Patrikelis, P., Stefanatou, M., Ntinopoulou, E., Verentzioti, A., Alexoudi, A., Stavrinou, L. C., Korfias, S. I., & Gatzonis, S. D. (2026) · Journal of Health Psychology · doi:10.1177/13591053261416350
“Sociodemographic characteristics such as female gender, lower educational status, and younger age (Jones et al., 2012; Podda et al., 2020; Wood et al., 2013) have been identified as significant correlates of anxiety in pwMS. Research indicates that a history of depression may increase the…”
Towards a unified view of metacognition : Insights from metamemory
Mazancieux, A. (2020) · theses.fr (ABES) · doi:10.70675/f37dcebbz4e30z4da4za014z74039ef3666f
Royer, N. (2022) · theses.fr (ABES) · doi:10.70675/f339adbaz4521z4a94zad19z62ea83348e19
THE IMPACT OF YOGA ON FATIGUE, POSTURAL CONTROL AND DEPRESSION IN PEOPLE WITH MULTIPLE SCLEROSIS
Külli, H. D., Kaya, M., Uçgun, H., & Telli, B. K. (2026) · Kırıkkale Üniversitesi Tıp Fakültesi Dergisi · doi:10.24938/kutfd.1624416
Alqwaifly, M., Almuqairsha, S. A., Alwashmi, E., Alharbi, Y. M., Aldubaiyan, A. A. R., Aldligan, R. H., Alkhamees, A. A., Abazid, A., Khalil, R., & Al‐Wutayd, O. (2026) · Clinics and Practice · doi:10.3390/clinpract16060114
MRI Correlates of Depression and Anxiety in Multiple Sclerosis
Pascu, L. S., Mitincu-Caramfil, S.-D., Brădeanu, A. V., Dinu, A., Lungu, M., MARINESCU, I., & Drima, E. P. (2026) · Diseases · doi:10.3390/diseases14070262
“It ranged from 18.5% [68] to 58.9% [69] among PwMS, reflecting the heterogeneity in research populations, diagnostic methods, and assessment tools.”
InfluentialWuana, R. A., Ibeh, M. C., Eneji, I. S., et al. (2026) · Journal of Geoscience and Environment Protection · doi:10.4236/gep.2026.149008
Metadata
- Authors
- Wood, B., van der Mei, I., Ponsonby, A.-L., Pittas, F., Quinn, S., Dwyer, T., Lucas, R., & Taylor, B.
- Affiliations
- University of Tasmania (AU)
- Menzies Research Institute Tasmania, University of Tasmania, Tasmania, Australia
- The University of Melbourne (AU)
- Flinders University (AU)
- National Centre for Epidemiology and Public Health, The Australian National University, Canberra, Australia
- Venue
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Published
- 2012-06-22
- Volume
- 19
- Issue
- 2
- Pages
- 217-224
- ISSN
- 1352-4585 (ISSN-L)
- 1477-0970
- OpenAlex
- W1973836236
- Cited by
- 294
- References
- 41
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 17 · 2023: 15 · 2022: 24 · 2021: 36 · 2020: 21 · 2019: 19 · 2018: 25 · 2017: 22 · 2016: 24 · 2015: 25 · 2014: 28 · 2013: 19 · 2012: 1
- FWCI
- 16.84
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Locations
- Multiple Sclerosis Journal (publishedVersion)
- PubMed (publishedVersion)
- eCite Digital Repository (University of Tasmania) (submittedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- ANU Open Research (Australian National University) (submittedVersion)
- Swinburne figshare (Swinburne University of Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- multiple sclerosis, anxiety, depression, fatigue, comorbidities, prevalence, longitudinal cohort, sex differences, disease duration, Expanded Disability Status Scale, seasonal variation, Hospital Anxiety and Depression Scale, Fatigue Severity Scale
- MeSH terms
- Adult, Age Factors, Antidepressive Agents, Anxiety, Depression, Disability Evaluation, Educational Status, Fatigue, Female, Humans, Immunologic Factors, Longitudinal Studies, Male, Middle Aged, Multiple Sclerosis, Seasons, Sex Characteristics, Tasmania, Cohort Studies, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review